Updates in advances in lung cancer
著者
書誌事項
Updates in advances in lung cancer
（Progress in respiratory research, vol. 29）
Karger, 1997
大学図書館所蔵 全4件
注記
Includes bibliographical references and index
内容説明・目次
内容説明
Lung cancer remains a major cause of cancer deaths throughout the world. It is an extremely lethal neoplasm: 80-90% of patients who develop lung cancer will die of their disease. The purpose of this book is to update cancer specialists, pulmonary physicians, thoracic surgeons and general practitioners about the many recent advances in the treatment, prevention and biology of lung cancer. Despite the overall poor prognosis for patients, a number of new chemotherapeutic drugs and regimens have been developed which result in a clinically meaningful improvement in survival for patients with nonsmall cell lung carcinoma. Four chapters in this book are devoted to reviewing these new drugs and drug combinations (paclitaxel, docetaxel, vinorelbine, gemcitabine, topoisomerase inhibitors). Advances in the management of locally advanced nonsmall cell and small cell lung cancer are considered, including combined-modality treatments using chemotherapy, surgery, and radiation therapy. Results of recent trials involving chemoprevention agents are also reported. Finally, the latest progress in understanding the molecular biology of this disease, and how it might impact on the clinical management of lung cancer patients, is discussed.
目次
- Part 1 Nonsmall cell lung cancer: stage 1 disease - lung cancer chemoprevention and management of carcinoma in situ, D.D. Karp and A. Law
- locally advanced nonsmall cell lung cancer - the role of chemotherapy and surgery in the treatment of locally advanced nonsmall cell lung cancer, D.W. Johnstone et al, role of chemotherapy and radiation therapy in the treatment of locally advanced nonsmall cell lung cancer, M.P. Mehta
- metastatic disease - treatment of stage IV nonsmall lung cancer, P.D. Bonomi, the emerging role of paclitaxel and carboplatin in nonsmall cell lung carcinoma, C.J. Langer, the use of gemcitabine in nonsmall cell lung cancer, U. Gatzenmeier and H.-D. Peters, the use of docetaxel in nonsmall cell lung cancer, J.F. Bishop and S.J. Clarke. Part 2 Small cell lung cancer: the role of radiation therapy in the treatment of patients with small cell lung cancer - when, where and how much is enough?, H. Wagner, Jr.
- new drug therapies for small cell carcinoma of the lung, J.H. Schiller
- palliative medicine in lung cancer, J.F. Cleary
- the molecular biology of lung cancer, T. Ishida and D.P. Carbone.
「Nielsen BookData」 より